These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET. Aerts HJ; Dubois L; Perk L; Vermaelen P; van Dongen GA; Wouters BG; Lambin P J Nucl Med; 2009 Jan; 50(1):123-31. PubMed ID: 19091906 [TBL] [Abstract][Full Text] [Related]
10. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]
11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
12. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2. van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932 [TBL] [Abstract][Full Text] [Related]
13. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591 [TBL] [Abstract][Full Text] [Related]
14. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462 [TBL] [Abstract][Full Text] [Related]